Midatech Pharma plc Total Liabilities 2011-2026 | MTP

Annual Total Liabilities Midatech Pharma plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.46 M	5.86 M	2.36 M	2.46 M	3.1 M	11.3 M	3.52 M	14.5 M	11 M	17.2 M	7.14 M	4.41 M	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
17.2 M	2.36 M	7.44 M

Quarterly Total Liabilities Midatech Pharma plc

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	2.46 M	-	-	-	3.1 M	-	-	-	11.3 M	-	-	-	3.52 M	-	-	-	14.5 M	-	-	-	11 M	-	-	-	17.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
17.2 M	2.46 M	9.01 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Adaptimmune Therapeutics plc ADAP	243 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
ANI Pharmaceuticals ANIP	855 M	$ 80.34	-	$ 1.55 B	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Aptorum Group Limited APM	4.35 M	$ 0.84	1.96 %	$ 4.58 M	China
I-Mab IMAB	707 M	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Adagene ADAG	38.7 M	$ 2.67	-	$ 150 M	China
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	5.89 M	$ 3.57	-	$ 8.59 B	Australia
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	90.7 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	272 M	$ 1.5	-	$ 281 M	USA
Aptose Biosciences APTO	14.7 M	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Ascendis Pharma A/S ASND	1.29 B	$ 222.03	-	$ 5 B	Danmark
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	3.12 B	$ 110.34	-	$ 27.2 B	Germany
Cabaletta Bio CABA	17.5 M	$ 2.44	-	$ 2.85 M	USA
Arena Pharmaceuticals ARNA	110 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	38.9 M	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	1.45 B	$ 8.97	-	$ 1.44 B	Britain
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	13.9 M	-	-	$ 269 M	USA
Athersys ATHX	28.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 4.22	-	$ 9.18 B	Israel
Autolus Therapeutics plc AUTL	355 M	$ 1.46	-	$ 373 M	Britain
Compugen Ltd. CGEN	18.5 M	$ 1.71	-	$ 153 M	Israel
Amneal Pharmaceuticals AMRX	3.32 B	$ 14.52	-	$ 4.49 B	USA
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel